Page 10 - Coll Cla News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Coll cla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Coll Cla Today - Breaking & Trending Today
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) CEO Joseph Ciaffoni sold 14,516 shares of the company’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $30.03, for a total transaction of $435,915.48. Following the completion of the transaction, the chief executive officer now directly owns 275,000 […] ....
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a report issued on Wednesday morning. Separately, Needham & Company LLC raised their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research report on Friday, August […] ....
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Needham & Company LLC increased their price objective on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research note on […] ....
StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday morning. Separately, Needham & Company LLC increased their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the company a buy rating in a research report on Friday, […] ....
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) saw a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 6,010,000 shares, a drop of 7.3% from the October 15th total of 6,480,000 shares. Approximately 17.8% of the shares of the company are short sold. Based […] ....